3 Reasons to Buy Pfizer Stock Like There's No Tomorrow

The pharmaceutical industry can be a tough business. Companies must innovate constantly to stay relevant because patents protecting their proprietary drugs expire. Pfizer (NYSE: PFE), a longtime stalwart in the pharmaceutical sector, enjoyed a growth spurt during the COVID-19 pandemic due to its Comirnaty vaccine and Paxlovid treatment.Sales and earnings have plunged since the pandemic ended, sending Pfizer stock down over 50% off its former high.Ironically, the best time to invest in cyclical companies like Pfizer is during these valleys, just before the next growth spurt. Although Pfizer seems headed toward big things over the coming years, the stock has immediate appeal. Here are three reasons to consider buying Pfizer like there's no tomorrow -- today.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool